Delhi on Monday reported 12,527 new Covid cases and 24 Deaths. The national capital’s active cases have declined to 83,982, while the positivity rate stands at 27.99%. The Centre, meanwhile, on Monday released new Covid treatment guidelines, which didn’t include the use of Molnupiravir. Using Remdesivir and Tocilizumab drug has been allowed but with certain conditions. Read More
Key EventsKey Events
Canada’s health authority said Monday it has approved Pfizer’s anti-Covid pill, Paxlovid, for adults at high risk of progressing to serious disease. The oral treatment was approved after an “expedited review,” Health Canada said in a statement on its website, adding that it would continue to monitor its safety and effectiveness.
When Covid cases are continuously surging, a society in the west Delhi area is fighting against the pandemic in the most simple yet effective way. Taking lessons from the second wave that swallowed 12 of its residents, the DG3 society of the Vikaspuri area has prepared for any possible surge. READ MORE
A total of five people died of COVID-19 in Rajasthan and 9,236 tested positive for the infection in the last 24 hours, the official data said on Monday. According to the Health Department figures, 9,236 new cases of coronavirus were reported in the state till Monday evening.
Bengal govt allows gyms to operate with 50% capacity, jatra performances too and film/tv shoots under Covid protocols
Delhi Health Minister Satyendar Jain on Monday said corona cases have decreased in the city over the last four days as the weekend curfew is proving to work and assured migrant workers there will be no lockdown in the national capital. He said the vaccination drive in Delhi completed one year on Monday and a total of 2.85 crore doses have been administered so far.
Molnupiravir Not Included In COVID-19 Treatment Guideline, Remdesivir (EUA) may be considered only in patients who are within 10 days of onset of symptoms. READ MORE
Maharashtra To Make It Mandatory To Have Doctor’s Prescription For Buying Covid Self Test Kit.
Gennova Biopharmaceuticals had filed its phase 2 data with Central Drugs Standard Control Organisation (CDSCO) on Friday. The Omicron specific variant of vaccine is under development & will be ready for human clinical trials, subject to regulatory approvals, says a company spokesperson
Active coronavirus cases in Andhra Pradesh crossed the 30,000 mark to reach 30,182 on Monday as 4,108 fresh positives were added in the state. In the 24 hours ending 9 am today, 22,882 samples were tested, which turned a positivity rate of about 19 per cent, a four per cent rise over Sunday.
Several countries across the world continue to battle the third wave of the coronavirus and have also ramped up the vaccination drives to protect their citizens from the deadly infection. Unfortunately, still, a little hesitancy is left among some people to get jabbed. In India, the government has made anyone with the age of 15 or above eligible to take the vaccine against the Covid-19. The development of safe and effective Covid vaccines is a huge step forward to end the pandemic, which has now also impacted the lives of children and young people. READ MORE
“Over 3.5 crore children between the 15-18 age group have received the first dose of COVID-19 vaccine, since 3rd January,” tweets Union Health Minister Dr Mansukh Mandaviya.
India may begin inoculating children in the 12-14 age group against COVID-19 in March as the 15-18 population is likely to get fully vaccinated by then, Dr N K Arora, chairman of the COVID-19 working group of NTAGI, said on Monday. Of the estimated 7.4 crore (7,40,57,000) population in the 15-18 age bracket, over 3.45 crore have received the first dose of Covaxin so far and their second dose is due in 28 days, he said.
967 schools with above 500 student beneficiaries each shall be transformed into vaccination centres from January 19 for children between the age group of 15 to 18 years. A total of 8.14 lakh students will get vaccinated: Kerala Education Minister V Sivankutty pic.twitter.com/MeoxC3pnBe
— ANI (@ANI) January 17, 2022
Amid a fresh spurt in Covid cases, the Mathura district judiciary on Monday curtailed its functioning, banning litigants to enter the court premises without permission and making judicial officers and other staffers work in rotation as elsewhere in Uttar Pradesh under an Allahabad High Court order, a district judiciary official said on Monday. The restrictions on courts functioning were announced on a day two Covid deaths were reported in the district.
Three infants have died in two villages in the district, after they were administered measles-rubella (MR) vaccine, officials said. The deceased are said to be between 10-15 months of age and are from Bochabal and Mallapur villages in Ramdurg taluk.
A plea on Monday urged the Delhi High Court to direct the Central government to give a road map for vaccinating children of the age group of 12 years and below for COVID-19. A bench of Chief Justice D N Patel and Justice Jyoti Singh said it would hear the plea on March 22.
Indore reported 1890 new Covid-19 cases yesterday, with 10,313 active cases. There are no serious symptoms in these cases, majority being under home isolation. 153 patients are hospitalized, 12 cases with comorbidities needed ICU & 28 needed oxygen-beds: Indore CMHO BS Setia
About 2,500 Delhi Police personnel have tested positive for COVID-19 since January 1 and 767 of them have recovered, an official said on Monday. According to the latest data, since January 1, about 2,500 Delhi Police personnel from all ranks and units of the force tested positive for Covid. Additional Commissioner of Police (Crime) Chinmoy Biswal who is also the spokesperson of Delhi Police had tested positive for the virus. He, however, has recovered and resumed work, a senior police officer said.
Odisha on Monday recorded 10,489 new COVID-19 cases, 688 less than the previous day, with the tally mounting to 11,44,401, a health department bulletin said. The death toll rose to 8,484 as three more patients – two in Bhubaneswar and one in Angul – succumbed to the disease, it said. Fifty-three other COVID patients have died due to comorbidities so far. The daily test positivity rate (TPR) stood at 14.96 per cent as the fresh infections were detected from 70,117 sample tests in the last 24 hours, the bulletin said. Khurda district, which comprises state capital Bhubaneswar, reported the highest number of new cases at 2,934, followed by Sundargarh at 1,447, Cuttack at 786 and Balasrore at 433, it said.
In the past 24 hours, India logged 2,58,089 fresh cases in the past 24 hours, as per the health ministry’s data. Global scientists have warned that Omicron won’t be the last version of the coronavirus to worry the world. The Centre has told the Supreme Court that COVID-19 inoculation guidelines issued by the Union health ministry do not envisage forcible vaccination without obtaining the consent of an individual.
After a successful inoculation drive for 15-17-year-olds, the Covid vaccination programme for age group 12-14 is all set to start from February-end, Dr N K Arora, chairman of the Covid-19 working group of the National Technical Advisory Group on Immunisation said. Pune-based Gennova has developed the mRNA vaccine for the rapidly spreading Omicron variant in the laboratory, which will be tested for human use for efficacy and immunogenicity soon, sources told the Times of India (TOI).
Reportedly, India may soon have its first messenger or mRNA vaccine soon, with the near completion of Phase 3 clinical trials by Gennova Biopharmaceuticals. The firm has recently submitted Phase 2 trial data of over 3,000 subjects of their two-dose mRNA vaccine developed on the delta variant, and is close to completing Phase 3 trials, sources told TOI.
A total of 3.31 crore children in the age bracket of 15 to 17 years have already received their first dose, accounting for almost 45% coverage, just 13 days into the drive on January 3 this year.
“We aim to cover all the 7.4 crore adolescents in the 15-17 age bracket with the first dose by January-end so that we can start vaccinating them with the second dose from early February and finish the second dose by February-end. We want to start vaccinating children between 12 and 14 years from February-end or early March,” Dr Arora told TOI.
Meanwhile, the UK government is reportedly planning to do away with the requirement of mandatory COVID-19 tests post-arrival into the country for fully vaccinated travellers, including from India, as part of preparations of having to live with coronavirus in the future.